Skip to content
VIDEO

Childhood Cancer Immunotherapy Program

VIDEO

New Childhood Brain Cancer Research

VIDEO

37 Years of Dedication

Video

Introducing the Telethon Kids Cancer Centre

VIDEO

Unlocking the key to leukaemia progression in kids

Today Tonight

The new sarcoma research team

video

Meet Finlay

VIDEO

The SJ Elliot Cancer Trial

April 2022

Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data

Pineoblastoma is a rare brain tumor usually diagnosed in children. Given its rarity, no pineoblastoma-specific trials have been conducted. Studies have included pineoblastoma accruing for other embryonal tumors over the past 30 years.

Children's Cancers Published research Brain Tumour Research Leukaemia Translational Research
July 2022

A novel skin cancer prevention strategy: Preservice teachers' perceptions of a sun safety intervention and experiences in schools

Teachers play a vital role in developing children's sun protection routines however upskilling preservice teachers (PSTs) while at university has not yet been trialled as a targeted skin cancer prevention strategy. Hence, this study investigated PSTs perceptions and experiences of sun safety following a brief pilot intervention and placement in primary schools in Western Australia.

Children's Cancers Published research Vitamin D and Sunlight School and Community Wellbeing
July 2022

Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model

Acute megakaryoblastic leukemia of Down syndrome (DS-AMKL) is a model of clonal evolution from a preleukemic transient myeloproliferative disorder requiring both a trisomy 21 (T21) and a GATA1s mutation to a leukemia driven by additional driver mutations.

Children's Cancers Published research Translational Genomics in Leukaemia Child disability
May 2022

The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression

Rearrangements of the Mixed Lineage Leukemia (MLL/KMT2A) gene are present in approximately 10% of acute leukemias and characteristically define disease with poor outcome.

Children's Cancers Published research Leukaemia Translational Research Subsite: Cancer